Immutep Limited

Immutep Limitedverified

IMMP

Price:

$1.98

Market Cap:

$487.62M

Immutep Limited, a biotechnology company, engages in the research and development of pharmaceutical product candidates. The company develops immunotherapeutic products for the treatment of cancer and autoimmune diseases. Its lead product candidate is eftilagimod alpha (efti or IMP321), a recombinant protein that is in Phase IIb clinical trial as a chemoimmunotherapy combination for metastatic breast cancer. The company also develops TACTI-002, which is in a Phase II clinical trial for the treatment of head and neck squamous cell carcinoma (HNSCC) and non-small cell lung cancer; TACTI-003 that is in Phase IIb clinical trial to treat HNSCC; and INSIGHT-004 and INSIGHT-003, which is in a Phase ...[Read more]

Industry

Biotechnology

IPO Date

2012-04-19

Stock Exchange

NASDAQ

Ticker

IMMP

The Enterprise Value as of December 2024 (TTM) for Immutep Limited (IMMP) is 365.43M

According to Immutep Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 365.43M. This represents a change of 404.24% compared to the average of 72.47M of the last 4 quarters.

Immutep Limited (IMMP) Historical Enterprise Value (quarterly & annually)

How has IMMP Enterprise Value performed in the past?

The mean historical Enterprise Value of Immutep Limited over the last ten years is 141.92M. The current 365.43M Enterprise Value has changed 25.65% with respect to the historical average. Over the past ten years (40 quarters), IMMP's Enterprise Value was at its highest in in the June 2012 quarter at 439.76M. The Enterprise Value was at its lowest in in the March 2016 quarter at 0.

Quarterly (TTM)
Annual

Average

141.92M

Median

139.74M

Minimum

44.49M

Maximum

252.93M

Immutep Limited (IMMP) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Immutep Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 468.50%

Maximum Annual Enterprise Value = 252.93M

Minimum Annual Increase = -50.58%

Minimum Annual Enterprise Value = 44.49M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
2023135.36M-10.68%
2022151.55M-40.08%
2021252.93M468.50%
202044.49M-50.58%
201990.02M-14.96%
2018105.86M1.44%
2017104.36M-28.72%
2016146.41M-40.02%
2015244.09M69.38%
2014144.11M-40.73%

Immutep Limited (IMMP) Average Enterprise Value

How has IMMP Enterprise Value performed in the past?

The current Enterprise Value of Immutep Limited (IMMP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

179.95M

5-year avg

134.87M

10-year avg

141.92M

Immutep Limited (IMMP) Enterprise Value vs. Peers

How is IMMP’s Enterprise Value compared to its peers?

Immutep Limited’s Enterprise Value is greater than CohBar, Inc. (-4359535.00), greater than Ocean Biomedical, Inc. (32.10M), greater than Elevation Oncology, Inc. (16.13M), greater than AVROBIO, Inc. (-85302404.00), greater than Zura Bio Limited (-36740010.00), less than CNS Pharmaceuticals, Inc. (0), greater than ZyVersa Therapeutics, Inc. (-779363.00), greater than eFFECTOR Therapeutics, Inc. (2.53M), greater than VectivBio Holding AG (4.74M), less than Enveric Biosciences, Inc. (848.58M), greater than null (117.26K),

Build a custom stock screener for Immutep Limited (IMMP) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Immutep Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Immutep Limited (IMMP) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Immutep Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is Immutep Limited's Enterprise Value?

What is the highest Enterprise Value for Immutep Limited (IMMP)?

What is the 3-year average Enterprise Value for Immutep Limited (IMMP)?

What is the 5-year average Enterprise Value for Immutep Limited (IMMP)?

How does the current Enterprise Value for Immutep Limited (IMMP) compare to its historical average?